Learn more

MORPHOCHEM AG

Overview
  • Total Patents
    79
About

MORPHOCHEM AG has a total of 79 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, Australia and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and machines are ADIR SRL, RHONE POULENC RORER PHARMA and SIONOGI EHND KO LTD.

Patent filings per year

Chart showing MORPHOCHEM AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Doemling Alexander 27
#2 Fuchs Thilo 19
#3 Cappi Michael W 16
#4 Weber Lutz 15
#5 Beck Barbara 12
#6 Eckl Robert 11
#7 Illgen Katrin 11
#8 Schabbert Silke 10
#9 Cappi Michael 8
#10 Richter Wolfgang 8

Latest patents

Publication Filing date Title
BRPI0617376A2 5-quinoline derivatives having an antibacterial activity
US2006046978A1 Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)
ZA200509147B Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10255681A1 New epothilone-like macrocyclic lactones or lactams containing thia group, useful for treating cancer diseases
DE10155727A1 Serine protease inhibitors
AU2169302A Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors
DE10150172A1 New 5-amino-4-phenyl-1H-imidazole derivatives useful as protein tyrosine phosphatase 1B inhibitors, for treating e.g. diabetes and obesity
DE10134172A1 New alpha-hydroxy-ketone derivatives, useful as intermediates for biologically active polyketides, terpenoids, epothilones and their derivatives
DE10117064A1 Device for the automatic dispensing of microscopic volumes of fluids
DE10113587A1 Process for the preparation of substituted pyrroles
AU4067301A Process for obtaining inhibitors/activators of an enzyme
DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis
DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis
DE10041402A1 Novel compounds that inhibit factor Xa activity
EP1144345A2 Method for the combinatorial search for reactions for producing useful products
DE10001729A1 Treatment or prevention of hepatitis C infection by administration of certain bicyclic compounds, e.g. 2-methyl-1,4-naphthoquinone
DE19955634A1 Coupling-condensation synthesis of heterocycles
DE19948417A1 Imidazole derivatives and their use as medicines
DE19947297A1 Cyclic biphenyls, processes for their preparation and their use as medicines